Home > Insider Trading > Filing (0001209191-23-056185)

Filing Details

Accession Number:: 0001209191-23-056185
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-11-20 21:31:40
Reporting Period:: 2023-11-16

Accepted Time:: 2023-11-20 21:31:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1641281	Bolt Biotherapeutics Inc.	BOLT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1227162	Edgar Engleman	C/O Bolt Biotherapeutics, Inc. 900 Chesapeake Drive Redwood City CA 94063		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-11-16	7,531	$0.96	1,989,685	No	4	S	Indirect	By Vivo Capital Fund VIII, L.P.
Common Stock	Disposition	2023-11-17	8,211	$0.93	1,981,474	No	4	S	Indirect	By Vivo Capital Fund VIII, L.P.
Common Stock	Disposition	2023-11-20	27,465	$0.92	1,954,009	No	4	S	Indirect	By Vivo Capital Fund VIII, L.P.
Common Stock	Disposition	2023-11-16	1,040	$0.96	274,749	No	4	S	Indirect	By Vivo Capital Surplus Fund VIII, L.P.
Common Stock	Disposition	2023-11-17	1,134	$0.93	273,615	No	4	S	Indirect	By Vivo Capital Surplus Fund VIII, L.P.
Common Stock	Disposition	2023-11-20	3,792	$0.92	269,823	No	4	S	Indirect	By Vivo Capital Surplus Fund VIII, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Vivo Capital Fund VIII, L.P.
No	4	S	Indirect	By Vivo Capital Fund VIII, L.P.
No	4	S	Indirect	By Vivo Capital Fund VIII, L.P.
No	4	S	Indirect	By Vivo Capital Surplus Fund VIII, L.P.
No	4	S	Indirect	By Vivo Capital Surplus Fund VIII, L.P.
No	4	S	Indirect	By Vivo Capital Surplus Fund VIII, L.P.

Footnotes

The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4.
The securities reported herein are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Fund VIII, L.P. The Reporting Person is one of the voting members of Vivo Capital VIII, LLC and may be deemed to have shared voting and dispositive power over the shares held by Vivo Capital Fund VIII, L.P. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.
The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.93 to $0.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (5) to this Form 4.
The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.92 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (6) to this Form 4.
The securities reported herein are held of record by Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC is the general partner of Vivo Capital Surplus Fund VIII, L.P. The Reporting Person is one of the voting members of Vivo Capital VIII, LLC and may be deemed to have shared voting and dispositive power over the shares held by Vivo Capital Surplus Fund VIII, L.P. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.